National and regional health insurers have begun to reimburse providers for electronic patient visits, in the hope these payments will improve care quality as well as doctor-patient relationships.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback